These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36867370)

  • 21. IL-1 Family Antagonists in Mouse and Human Skin Inflammation.
    Martin P; Goldstein JD; Mermoud L; Diaz-Barreiro A; Palmer G
    Front Immunol; 2021; 12():652846. PubMed ID: 33796114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome.
    Hayran Y; Allı N; Yücel Ç; Akdoğan N; Turhan T
    Arch Dermatol Res; 2020 Apr; 312(3):187-196. PubMed ID: 31722038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spesolimab: a comprehensive review on the anti-IL-36 receptor antibody in dermatology.
    Palaniappan V; Gopinath H; Murthy AB; Radhakrishnan S; Karthikeyan K
    Int J Dermatol; 2024 Jan; 63(1):88-93. PubMed ID: 38031264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease.
    Andoh A; Nishida A
    J Gastroenterol; 2023 Feb; 58(2):69-78. PubMed ID: 36376594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa.
    Thomi R; Kakeda M; Yawalkar N; Schlapbach C; Hunger RE
    J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2091-2096. PubMed ID: 28602023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of interleukin-36 in health and disease states.
    Sugiura K; Fujita H; Komine M; Yamanaka K; Akiyama M
    J Eur Acad Dermatol Venereol; 2024 Oct; 38(10):1910-1925. PubMed ID: 38779986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-36 cytokines and gut immunity.
    Ngo VL; Kuczma M; Maxim E; Denning TL
    Immunology; 2021 Jun; 163(2):145-154. PubMed ID: 33501638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability.
    Joo YH; Kim HK; Hak Choi I; Han HM; Lee KJ; Kim TH; Lee SH
    Cytokine; 2020 Jan; 125():154798. PubMed ID: 31430658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-36α and IL-36γ expressions in the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema: A retrospective histopathologic and immunohistochemical study.
    Erdem O; Leblebici C; Koku Aksu AE; Erdil D; Kara Polat A; Gürel MS
    J Cutan Pathol; 2022 Jan; 49(1):42-48. PubMed ID: 34289144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases.
    Walsh PT; Fallon PG
    Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mature IL-36γ Induces Stratum Corneum Exfoliation in Generalized Pustular Psoriasis by Suppressing Corneodesmosin.
    Sato E; Imayoshi H; Tsutsui Y; Shimizu H; Imafuku S
    J Invest Dermatol; 2024 Apr; 144(4):764-773.e4. PubMed ID: 37827276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-36 Cytokines: Their Roles in Asthma and Potential as a Therapeutic.
    Dong H; Hao Y; Li W; Yang W; Gao P
    Front Immunol; 2022; 13():921275. PubMed ID: 35903102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
    Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
    PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1 Superfamily Members and Periodontal Diseases.
    Papathanasiou E; Conti P; Carinci F; Lauritano D; Theoharides TC
    J Dent Res; 2020 Dec; 99(13):1425-1434. PubMed ID: 32758110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
    Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
    J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
    Milora KA; Fu H; Dubaz O; Jensen LE
    J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
    Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation and function of interleukin-36 cytokines.
    Bassoy EY; Towne JE; Gabay C
    Immunol Rev; 2018 Jan; 281(1):169-178. PubMed ID: 29247994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.